Market Overview

American Capital Receives $127M from Sale of Paradigm Precision Holdings

Related ACAS
American Capital Raises $510M Managed CLO
Atossa Genetics and AAIPharma / Cambridge Major Laboratories Announce Manufacturing Agreement For Atossa's Lead Drug Candidate Afimoxifene Gel
Elliott strikes confidentiality pact with American Capital, ups stake to 9.1% (Seeking Alpha)

American Capital, Ltd. (Nasdaq: ACAS) ("American Capital") announced today that its portfolio company Paradigm Precision Holdings, LLC ("Paradigm Precision") was sold to Dynamic Precision Group, a portfolio company of The Carlyle Group (NASDAQ: CG), on January 31, 2013. American Capital and its affiliated funds have received $129 million in debt and equity proceeds, subject to post-closing adjustments, of which $127 million was received by American Capital. American Capital's compounded annual rate of return earned on its senior debt, subordinated debt and equity investments since the first quarter of 2007 was 11%, including interest, dividends and fees earned over the life of its investment.

Posted-In: News Asset Sales


Related Articles (ACAS + CG)

Get Benzinga's Newsletters